Results of an autopsy-based study revealed that sudden cardiac death and multiorgan pathology may be more closely linked to SSc than previously thought.

The UAB researchers showed that TREM2 — which stands for triggering receptors expressed on myeloid cells 2 — is predominantly ...

Although the SYMMETRY Phase IIb trial of the FGF21 analogue efruxifermin did not meet its primary endpoint at 36 weeks, ...

Announcing a new article publication for BIO Integration journal. Liver fibrosis is caused by excessive extracellular matrix ...

Peter Moulding joined a clinical trial for the drug AMP945 not really knowing whether it would help him with deadly stage ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

DelveInsight's NADPH Oxidase (NOX)-Replacement Therapies Market Size, Target Population, Competitive Landscape & Market ...

Altimmune, Inc.'s Pemvidutide shows promise in MASH treatment with liver improvements and safety, despite market overreaction. Click for my ALT stock update.

In interstitial lung disease (ILD), quantitative computed tomography (qCT) is effective for prognosticating and for disease monitoring.

Myocardial fibrosis was significantly more common among individuals with SSc vs controls (82% vs 31%; OR, 10.7; 95% CI, 4.1-28.7; P <.01). Fibrosis could not be explained by coronary artery disease, ...